FBR Capital Maintains an 'Outperform' Rating on Healthways (HWAY); 3Q10 Embracing the Change, but Feeling the Near-Term Pain
Tweet Send to a Friend
FBR Capital maintains an 'Outperform' rating on Healthways Inc. (Nasdaq: HWAY), lowers PT from $19 to $17.
FBR analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
